In this study, we found that the risk score was not significantly associated with TMB, while it was significantly associated with multiple ICB-associated genes, including CD 274 and CTLA4 LAG3, suggesting that the tumor immune microenvironment (TIME) and ICB-associated genes were closely associated with radiotherapy sensitivity. The gene discussed is LAG3; the disease is neoplasm.